StockData
Armata Pharmaceuticals, Inc. logo

Armata Pharmaceuticals, Inc. (ARMP) stock

ARMPNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$2.66−0.33 (-11.04%)

Close on Nov 17, 2026Market cap $98.90MP/E –Yield –

Armata Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Armata Pharmaceuticals's price to book ratio was 4.2× on Oct 31, 2023, against 2.0× a year earlier. Over the last 5 years it ranged from 0.8× to 6.5×, with a median of 2.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Oct 31, 20234.2×+3.3
2022Dec 30, 20221.0×−4.8
2021Dec 31, 20215.8×+3.5
2020Dec 31, 20202.3×+0.5
2019Dec 31, 20191.8×+1.0
2018Dec 31, 20180.8×−1.2
2017Dec 29, 20171.9×+1.4
2016Dec 30, 20160.5×−2.5
2015Dec 31, 20153.0×−15.0
2014Dec 31, 201418.0×–

More Armata Pharmaceuticals figures

See a number that looks wrong?